This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Motor neuron disease (with DMD)
MND
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpoints |
919 |
6. Filter based on genotype QC (FinnGen only) |
831 |
Extra metadata
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- G710
- Name in latin
- Dystrophia musculorum gravis (Duchenne)
Similar endpoints
↥List of similar endpoints to
Motor neuron disease (with DMD)
based on the number of shared cases.
Similar with more cases:
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 831 | 347 | 484 |
| Unadjusted period prevalence (%) | 0.18 | 0.12 | 0.22 |
| Median age at first event (years) | 68.06 | 68.31 | 67.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 848
- Matched controls
- 8480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J96.1
ICD-10 Finland
Chronic respiratory failure
45.5
307.7
233
70
JDB10
NOMESCO Finland
Percutaneous gastrostomy
127.2
307.7
196
20
G12.2
ICD-10 Finland
Motor neuron disease
4503599627370496.0
307.7
792
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
109.5
307.7
243
31
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
21.9
264.2
212
127
N28
ICPC
Limited function/disability (N)
124.3
250.4
127
12
R4130
NOMESCO Finland
Speech therapy
52.4
247.3
144
33
N99
ICPC
Neurological disease other
767.7
241.7
227
*
N07XX02
ATC
riluzole; oral
+∞
236.9
216
*
R13
ICD-10 Finland
Dysphagia
16.0
236.0
226
188
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
28.2
228.6
161
70
Z51.5
ICD-10 Finland
Palliative care
10.2
221.7
321
480
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
19.8
201.7
166
103
TAB00
NOMESCO Finland
Lumbar puncture
42.8
188.9
115
31
R47.1
ICD-10 Finland
Dysarthria and anarthria
687.9
175.1
167
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
38.1
151.8
95
28
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
10.0
150.2
194
244
A28
ICPC
Limited function/disability NOS
6.7
142.7
296
628
G47.3
ICD-10 Finland
Sleep apnoea
13.3
141.9
144
128
SPAT1229
SPAT
Assessment of need for aid
12.0
128.3
139
136
XG466
NOMESCO Finland
Sleep oxymetry
25.7
123.7
88
38
M03BX01
ATC
baclofen; systemic
72.7
123.3
67
10
R5140
NOMESCO Finland
Monitoring the use of the aid
13.0
122.8
125
111
L28
ICPC
Limited function/disability (L)
5.9
116.3
271
630
R1250
NOMESCO Finland
Evaluation of functional capability
32.3
113.1
74
25
R4120
NOMESCO Finland
Occupational therapy
10.9
109.3
126
134
N03AE01
ATC
clonazepam; systemic
20.0
107.6
85
47
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
50.5
104.9
61
13
WX725
NOMESCO Finland
Noninvasive ventilation
8.5
100.8
142
195
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.3
94.6
112
123
R4190
NOMESCO Finland
Nutritional therapy
10.0
90.1
109
123
N29
ICPC
Neurological sympt/complt other
40.3
86.5
53
14
N05AH04
ATC
quetiapine; oral
9.6
79.0
98
114
D21
ICPC
Swallowing problem
33.1
77.2
50
16
N02AA01
ATC
morphine; systemic, rectal
10.9
74.9
84
85
XA800
NOMESCO Finland
Neuropsychological investigation
37.4
73.6
46
13
R1260
NOMESCO Finland
Evaluation of communicative skills
23.0
73.3
54
25
N19
ICPC
Speech disorder
25.1
73.1
52
22
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
9.8
71.7
87
98
R5599
NOMESCO Finland
Other rehabilitation service
12.4
70.6
72
63
S06.0
ICD-10 Finland
Concussion
13.1
70.1
69
57
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.6
68.3
194
514
SPAT1231
SPAT
Assessment of adjustments needed in living environment
25.4
67.8
48
20
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.6
66.6
117
202
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
10.6
65.1
74
76
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
8.1
64.7
92
126
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
30.1
64.5
43
15
AA1AD
NOMESCO Finland
CT of head and brain
4.1
64.0
219
665
N06AB10
ATC
escitalopram; oral
5.4
61.6
135
287
N06AX11
ATC
mirtazapine; oral
3.8
61.2
245
827
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
19.8
60.0
47
25
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
25.9
59.8
42
17
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
10.1
59.7
70
75
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
59.1
56
*
N05BA04
ATC
oxazepam; oral
3.8
56.2
207
657
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
6.2
56.1
103
185
SPAT1216
SPAT
Assessment of functional ability
4.2
53.8
170
483
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
11.9
53.1
55
49
XA402
NOMESCO Finland
ENMG
19.2
52.9
42
23
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.3
52.6
72
94
N05BA06
ATC
lorazepam; systemic, sublingual
9.4
51.1
63
72
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
50.9
186
584
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
97.9
50.5
55
6
N18
ICPC
Paralysis/weakness
84.0
49.6
55
7
TJD20
NOMESCO Finland
Change of gastrostomy tube
73.3
48.7
55
8
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
18.0
46.5
38
22
SPAT1245
SPAT
Provision of support and information to patient’s family members
8.8
46.3
60
73
F32.9
ICD-10 Finland
Depressive episode, unspecified
13.6
46.3
44
34
F51.0
ICD-10 Finland
Nonorganic insomnia
+∞
45.2
43
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.8
43.0
152
463
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.9
42.7
80
146
R5110, ,
SPAT
4.4
41.9
114
287
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
81.1
41.3
46
6
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
12.7
40.4
40
33
N05AX08
ATC
risperidone; systemic
13.1
40.3
39
31
SPAT1215
SPAT
Assessment of need for medical rehabilitation
8.1
38.6
53
69
G72.9
ICD-10 Finland
Myopathy, unspecified
394.4
38.4
38
*
SPAT1234
SPAT
Support of social functional capacity
7.3
38.2
58
85
N06AB04
ATC
citalopram; systemic
3.9
38.0
127
371
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
57.9
37.7
44
8
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
35.9
123
365
N02AA05
ATC
oxycodone; systemic
2.9
35.9
212
876
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
33.6
32
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.7
32.6
36
35
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
32.5
31
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.0
31.1
70
150
N03AX12
ATC
[U] gabapentin; oral
3.4
30.9
121
391
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.4
30.4
32
29
G56.0
ICD-10 Finland
Carpal tunnel syndrome
6.2
29.5
52
89
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
68.5
29.1
33
5
A06AD11
ATC
lactulose; oral
3.1
28.5
137
500
R25.3
ICD-10 Finland
Fasciculation
66.4
28.1
32
5
F80.1
ICD-10 Finland
Expressive language disorder
290.7
27.9
28
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.5
27.8
72
173
Z31.5
ICD-10 Finland
Genetic counselling
4.8
27.5
65
145
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
27.2
26
*
N06AX21
ATC
duloxetine; oral
4.5
27.0
68
160
XG416
NOMESCO Finland
Measurement of maximal airway pressure
+∞
26.2
25
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
26.1
233
1158
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
25.5
265
1405
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
25.1
24
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
25.1
24
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
40.2
25.0
31
8
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.3
24.8
28
28
R4120, ,
SPAT
30.2
24.2
32
11
SPAT1254
SPAT
Administration of medicine
2.9
24.1
128
492
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
+∞
24.1
23
*
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
246.7
23.8
24
*
ACC51
NOMESCO Finland
Release of median nerve
55.7
23.2
27
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
23.0
251
1349
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
66.9
22.9
26
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
9.6
22.7
27
29
NXL00
NOMESCO Finland
Biopsy of muscle
236.1
22.7
23
*
G20
ICD-10 Finland
Parkinson disease
236.1
22.7
23
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
21.4
22.7
33
16
GX2D5
NOMESCO Finland
Sleep oximetry
123.4
22.7
24
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
22.4
177
827
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
22.2
242
1296
G30.1
ICD-10 Finland
Alzheimer disease with late onset
53.5
22.2
26
5
N03AF01
ATC
carbamazepine; oral, rectal
6.7
21.9
35
54
SPAT1240
SPAT
Therapeutic discussion
5.1
21.8
47
97
T05
ICPC
Feeding problem of adult
32.1
21.6
28
9
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.5
21.4
54
127
N05CF01
ATC
zopiclone; oral
2.2
21.2
228
1212
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
8.2
21.0
28
35
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
20.9
20
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
20.9
20
*
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
20.9
20
*
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
112.8
20.7
22
*
S01.0
ICD-10 Finland
Open wound of scalp
3.5
20.4
73
221
J96.0
ICD-10 Finland
Acute respiratory failure
8.2
20.1
27
34
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
19.9
19
*
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
16.9
19.8
31
19
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
18.8
18
*
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
17.6
18.8
29
17
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.8
18.7
58
159
N06AA09
ATC
amitriptyline; systemic
3.7
18.7
60
169
R53
ICD-10 Finland
Malaise and fatigue
2.3
18.5
157
753
WX722
NOMESCO Finland
PEEP
5.3
18.3
37
72
R49.08
ICD-10 Finland
Other specified dysphonia
7.1
17.9
27
39
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
17.8
84
301
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
6.9
17.5
27
40
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
29.5
17.5
23
8
Z2445
NOMESCO Finland
Psychologist
19.1
17.4
26
14
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
17.8
17.0
26
15
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
16.8
75
260
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
64.7
16.8
19
*
XG410
NOMESCO Finland
Flow-volume spirometry
4.1
16.7
47
120
R47.0
ICD-10 Finland
Dysphasia and aphasia
173.3
16.6
17
*
N05BA01
ATC
diazepam; systemic, rectal
2.9
16.5
84
314
N06DA02
ATC
donepezil; oral
40.9
16.4
20
5
N06AX16
ATC
venlafaxine; oral
3.7
16.3
54
155
R06.0
ICD-10 Finland
Dyspnoea
2.0
16.3
215
1221
Z50.5
ICD-10 Finland
Speech therapy
13.1
16.2
28
22
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.5
16.1
40
93
XX9TE
NOMESCO Finland
Compementary ultrasound examination
25.0
16.1
22
9
N06AX26
ATC
vortioxetine; oral
6.3
16.0
27
44
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
15.7
15
*
RS314, ,
NOMESCO Finland
+∞
15.7
15
*
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
+∞
15.7
15
*
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
15.7
15
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
15.7
15
*
M48.0
ICD-10 Finland
Spinal stenosis
2.6
15.6
97
401
N04BC05
ATC
pramipexole; oral
3.8
15.6
49
136
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
16.4
15.3
24
15
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
20.5
15.2
22
11
SPAT1139
SPAT
Nutrition survey
5.1
15.1
32
65
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.0
14.8
42
108
ZY010
NOMESCO Finland
Hospital outpatient
4.9
14.8
33
70
N03AG01
ATC
valproic acid; systemic, rectal
18.8
14.7
22
12
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
14.6
14
*
Z3226
NOMESCO Finland
Physiotherapist
2.2
14.6
144
730
N06AB06
ATC
sertraline; oral
3.8
14.6
45
123
Z50.1
ICD-10 Finland
Other physical therapy
3.5
14.6
52
157
G40.9
ICD-10 Finland
Epilepsy, unspecified
152.5
14.5
15
*
K90
ICPC
Stroke/cerebrovascular accident
36.7
14.5
18
5
R4110
NOMESCO Finland
Physiotherapy
1.9
14.3
230
1388
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
27.7
14.3
19
7
L19
ICPC
Muscle symptom/complaint NOS
5.2
14.2
29
57
A29
ICPC
General symptom/complaint other
2.3
14.1
119
566
A04
ICPC
Weakness/tiredness general
2.4
13.7
102
459
N87
ICPC
Parkinsonism
142.2
13.5
14
*
G56.2
ICD-10 Finland
Lesion of ulnar nerve
21.6
13.4
19
9
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
11.7
13.4
24
21
N06DX01
ATC
memantine; oral
40.8
13.2
16
*
RK110, ,
NOMESCO Finland
15.3
13.1
21
14
M54.1
ICD-10 Finland
Radiculopathy
4.4
13.0
33
78
SPAT1262
SPAT
Handing over of treatment supplies
2.1
13.0
133
683
N05AH03
ATC
olanzapine; systemic
13.3
13.0
22
17
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.8
12.9
69
264
G62.8
ICD-10 Finland
Other specified polyneuropathies
50.8
12.9
15
*
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
4.2
12.9
34
83
SPAT1167
SPAT
Insertion of urinary catheter
4.0
12.8
36
92
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
71.0
12.6
14
*
WPA42
NOMESCO Finland
Family-centered psychosocial intervention in palliative care
71.0
12.6
14
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
10.3
12.5
24
24
R41.0
ICD-10 Finland
Disorientation, unspecified
9.5
12.5
25
27
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
12.5
12
*
K11.72
ICD-10 Finland
Xerostomia
+∞
12.5
12
*
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
12.5
12
*
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
+∞
12.5
12
*
L99
ICPC
Musculoskeletal disease other
5.0
12.2
26
53
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.2
12.2
19
12
WPA13
NOMESCO Finland
Palliative consultation
12.6
12.2
21
17
N03AX16
ATC
[U] pregabalin
2.1
12.1
134
707
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
12.1
141
759
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
12.0
68
1499
SPAT1301
SPAT
No procedures
1.8
12.0
222
1392
WW200, ,
SPAT
0.5
11.9
92
1797
N05AN01
ATC
lithium; oral
47.4
11.9
14
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
47.4
11.9
14
*
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
12.8
11.7
20
16
U04
ICPC
Incontinence urine
3.1
11.6
48
159
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
65.9
11.6
13
*
GX1P5
NOMESCO Finland
Nocturnal CO2 monitoring
65.9
11.6
13
*
J96.9
ICD-10 Finland
Respiratory failure, unspecified
13.9
11.5
19
14
RS142, ,
NOMESCO Finland
+∞
11.5
11
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
+∞
11.5
11
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
11.5
11
*
RS310, ,
NOMESCO Finland
+∞
11.5
11
*
WX723
NOMESCO Finland
CPAP therapy
+∞
11.5
11
*
Z93.1
ICD-10 Finland
Gastrostomy status
121.6
11.5
12
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
8.5
11.3
24
29
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
11.3
122
2127
WPA43
NOMESCO Finland
A doctor's home visit to perform palliative care
25.4
11.2
15
6
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
25.4
11.2
15
6
P03
ICPC
Feeling depressed
4.0
11.1
31
79
RS340, ,
NOMESCO Finland
43.9
10.9
13
*
N07AA02
ATC
pyridostigmine; systemic
60.8
10.6
12
*
RS211, ,
NOMESCO Finland
60.8
10.6
12
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.0
10.5
30
78
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
111.4
10.4
11
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
111.4
10.4
11
*
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
111.4
10.4
11
*
Z2446
NOMESCO Finland
Social worker
3.0
10.4
47
164
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
10.4
10
*
A210_, ,
NOMESCO Finland
+∞
10.4
10
*
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
+∞
10.4
10
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
10.4
10
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
10.4
10
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
10.4
10
*
A120_, ,
NOMESCO Finland
+∞
10.4
10
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
10.4
69
294
G44.2
ICD-10 Finland
Tension-type headache
2.9
10.4
50
181
RS222, ,
NOMESCO Finland
12.2
10.4
18
15
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
33.0
10.3
13
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
8.9
10.3
21
24
UJC01
NOMESCO Finland
Scopy of lower throat
8.9
10.3
21
24
WPA10, ,
SPAT
23.7
10.3
14
6
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
10.1
28
71
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.3
10.1
20
22
P20
ICPC
Memory disturbance
2.4
9.9
71
314
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
10.8
9.8
18
17
R06.5
ICD-10 Finland
Mouth breathing
2.9
9.8
47
170
WYA20
NOMESCO Finland
Home visit
9.7
9.8
19
20
F29
ICD-10 Finland
Unspecified nonorganic psychosis
55.6
9.7
11
*
F34.1
ICD-10 Finland
Dysthymia
55.6
9.7
11
*
G72.8
ICD-10 Finland
Other specified myopathies
55.6
9.7
11
*
N06DA03
ATC
rivastigmine; oral, transdermal
55.6
9.7
11
*
RS122, ,
NOMESCO Finland
55.6
9.7
11
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
55.6
9.7
11
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
55.6
9.7
11
*
RS311, ,
NOMESCO Finland
55.6
9.7
11
*
W19
ICD-10 Finland
Unspecified fall
2.4
9.6
64
274
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
101.1
9.4
10
*
RS313, ,
NOMESCO Finland
101.1
9.4
10
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
17.8
9.4
14
8
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
9.4
9
*
G71.03
ICD-10 Finland
Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker
+∞
9.4
9
*
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
9.4
9
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
9.4
9
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
9.4
9
*
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
9.4
9
*
GX1D5
NOMESCO Finland
Flow volume spirometry
22.0
9.4
13
6
IGY02
NOMESCO Finland
Psychiatric monitoring contact
22.0
9.4
13
6
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
9.4
87
429
SPAT1252
SPAT
Overall medication plan or its review
2.6
9.2
52
205
SPAT1125
SPAT
Stoma care and guidance
5.1
9.1
19
38
P29
ICPC
Psychological sympt/compl other
4.5
9.1
22
50
SPAT1276
SPAT
Outlining of treatment with patient or their family members
4.9
9.1
20
42
S28
ICPC
Limited function/disability (S)
11.6
9.1
16
14
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.7
9.1
48
183
WPA44, ,
SPAT
15.8
9.1
14
9
A98
ICPC
Health maint/preventive medicine
0.6
9.0
643
7132
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
37.1
9.0
11
*
N05CD07
ATC
temazepam; oral
2.3
9.0
71
328
N03AX09
ATC
lamotrigine; oral
18.8
8.9
13
7
WPA44
NOMESCO Finland
Nursing home for palliative care
18.8
8.9
13
7
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
24.3
8.9
12
5
N06AB03
ATC
fluoxetine; oral
2.6
8.9
53
215
RS221, ,
NOMESCO Finland
8.7
8.8
18
21
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
8.8
100
532
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
8.7
32
99
JDB00
NOMESCO Finland
Gastrostomy
50.5
8.7
10
*
R4130, ,
SPAT
50.5
8.7
10
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
50.5
8.7
10
*
SPAT1172
SPAT
Guidance concerning hydration
4.8
8.6
19
40
F03
ICD-10 Finland
Unspecified dementia
8.3
8.6
18
22
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
16.5
8.6
13
8
EB1VA, ,
NOMESCO Finland
0.3
8.4
25
754
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
8.4
36
122
N81
ICPC
Injury nervous system other
90.9
8.4
9
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
90.9
8.4
9
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
90.9
8.4
9
*
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
8.3
8
*
R27.0
ICD-10 Finland
Ataxia, unspecified
+∞
8.3
8
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
8.3
8
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
8.3
8
*
A220_, ,
NOMESCO Finland
+∞
8.3
8
*
EB4VA, ,
NOMESCO Finland
0.3
8.3
22
704
ZYC01
NOMESCO Finland
Remote contact by phone
2.8
8.3
41
151
130
Kela drug reimbursment
Malignant tumour
0.3
8.3
19
658
G04BD12
ATC
mirabegron; oral
2.0
8.2
86
443
RS230, ,
NOMESCO Finland
14.6
8.2
13
9
WPA43, ,
SPAT
11.8
8.1
14
12
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
33.7
8.1
10
*
XA421
NOMESCO Finland
Nocturnal polygraphy
33.7
8.1
10
*
OAB50
NOMESCO Finland
Delivery of care equipment and instruction on their use
33.7
8.1
10
*
WPA40
NOMESCO Finland
Individual-centered psychosocial intervention in palliative care
33.7
8.1
10
*
Z75.5
ICD-10 Finland
Holiday relief care
33.7
8.1
10
*
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
17.4
8.1
12
7
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
9.0
8.1
16
18
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.7
8.1
25
69
M03BX02
ATC
tizanidine; oral
1.5
8.0
403
3172
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
8.0
84
434
A06AH03
ATC
naloxegol; oral
4.3
8.0
20
47
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
4.5
7.9
19
43
WPA11
NOMESCO Finland
Developing a plan for palliative care
13.2
7.9
13
10
Z3231
NOMESCO Finland
Registered nurse
1.7
7.9
188
1248
H02AB02
ATC
dexamethasone; systemic
0.3
7.9
23
699
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
7.8
45
180
R1420
NOMESCO Finland
Assessment of rehabilitation needs and/or compilation of rehabilitation plan
45.4
7.7
9
*
G30.8
ICD-10 Finland
Other Alzheimer disease
45.4
7.7
9
*
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
45.4
7.7
9
*
N05AX12
ATC
aripiprazole; systemic
45.4
7.7
9
*
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
8.1
7.6
16
20
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.5
7.6
26
77
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.9
7.6
22
58
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
10.1
7.5
14
14
OAA67, ,
SPAT
0.3
7.5
15
561
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.1
7.4
*
268
N04AA02
ATC
biperiden; systemic
80.8
7.4
8
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
80.8
7.4
8
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
80.8
7.4
8
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
80.8
7.4
8
*
R42
ICD-10 Finland
Dizziness and giddiness
1.7
7.3
137
851
Z73.6
ICD-10 Finland
Limitation of activities due to disability
11.0
7.3
13
12
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
7.3
7
*
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
7.3
7
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
7.3
7
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
7.3
7
*
H02AB13
ATC
deflazacort; oral
+∞
7.3
7
*
34800
ICD-8 Finland
Motor neurone disease, Amyotrophic lateral sclerosis
+∞
7.3
7
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
7.3
7
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
7.3
7
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
7.3
7
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
7.1
92
511
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.1
7.1
19
47
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
7.1
137
2073
RK320, ,
NOMESCO Finland
12.2
7.1
12
10
R63.4
ICD-10 Finland
Abnormal weight loss
2.7
7.1
36
135
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
7.0
55
253
L01BC06
ATC
capecitabine; oral
0.1
7.0
*
252
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.9
6.9
18
31
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
13.9
6.9
11
8
N05AA02
ATC
levomepromazine; systemic
8.4
6.8
14
17
F06.7
ICD-10 Finland
Mild cognitive disorder
8.4
6.8
14
17
A04AA02
ATC
granisetron; systemic, transdermal
0.2
6.8
8
348
M60.9
ICD-10 Finland
Myositis, unspecified
16.8
6.8
10
6
N02BF01
ATC
gabapentin; oral
2.3
6.7
52
238
N06AX03
ATC
mianserin; oral
3.9
6.7
19
49
R33
ICD-10 Finland
Retention of urine
2.0
6.7
69
354
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
22.7
6.7
9
*
WPA41
NOMESCO Finland
Psychosocial conversational support in palliative care
22.7
6.7
9
*
C10AA07
ATC
rosuvastatin; oral
0.6
6.7
121
1864
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.6
346
2715
R28
ICPC
Limited function/disability (R)
4.2
6.6
17
41
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
8.8
6.6
13
15
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
10.1
6.5
12
12
R03BA08
ATC
ciclesonide; inhalant
2.2
6.5
52
242
N04BD01
ATC
selegiline; oral
70.4
6.4
7
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
70.4
6.4
7
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
70.4
6.4
7
*
N06AA12
ATC
doxepin; systemic
3.0
6.4
27
91
G51.0
ICD-10 Finland
Bell palsy
14.4
6.4
10
7
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
3.1
6.4
26
86
Z29
ICPC
Social problem NOS
6.6
6.4
15
23
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
6.3
31
114
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.4
6.3
22
66
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.1
6.3
11
10
F43.29
ICD-10 Finland
Adaptation disorder UNS
9.3
6.3
12
13
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
+∞
6.3
6
*
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
+∞
6.3
6
*
A123_, ,
NOMESCO Finland
+∞
6.3
6
*
A211_, ,
NOMESCO Finland
+∞
6.3
6
*
G83.2
ICD-10 Finland
Monoplegia of upper limb
+∞
6.3
6
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
6.3
6
*
N04BC04
ATC
ropinirole; oral
+∞
6.3
6
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
6.3
6
*
RK410, ,
NOMESCO Finland
+∞
6.3
6
*
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
+∞
6.3
6
*
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
+∞
6.3
6
*
N86
ICPC
Multiple sclerosis
+∞
6.3
6
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
+∞
6.3
6
*
N05BA09
ATC
clobazam; oral
+∞
6.3
6
*
RP120, ,
NOMESCO Finland
+∞
6.3
6
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
6.3
6
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
+∞
6.3
6
*
A222_, ,
NOMESCO Finland
+∞
6.3
6
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
26.9
6.2
8
*
D28
ICPC
Limited function/disability (D)
26.9
6.2
8
*
RD210, ,
NOMESCO Finland
5.1
6.2
18
36
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
8.7
6.1
12
14
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
6.1
52
249
N05CD08
ATC
midazolam; nasal, systemic
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
105
28
42.66
172.69
1.2
1.8
545.37
804.74
e6/l
0.11
82
19
104
27
43.76
172.20
1.1
1.8
7.71
35.00
e6/l
0.56
75
17
88
12
81.71
164.82
1.0
1.1
—
—
—
0
0
478
1437
6.33
160.47
2.5
1.8
409.65
190.94
u/l
1.71
462
1350
209
294
9.11
147.80
2.6
2.4
18.59
22.40
au/ml
0.24
15
40
194
274
8.88
136.19
1.4
1.3
69.71
49.89
au/ml
—
7
36
182
291
7.69
113.70
4.8
4.5
3.44
1.85
mmol/l
5.23
165
218
91
8
127.22
85.81
1.0
1.0
—
—
—
0
0
84
8
116.38
78.49
1.1
1.0
—
—
—
0
0
191
546
4.22
60.36
1.6
3.0
67.83
65.90
g/l
3.58
178
510
114
235
5.45
53.59
1.4
2.2
2.47
3.04
g/l
7.70
108
216
117
256
5.14
51.33
1.4
2.1
3.40
3.87
g/l
1.87
110
237
117
256
5.14
51.33
1.4
2.1
6.68
7.37
g/l
4.87
111
238
117
256
5.14
51.33
1.4
2.1
4.19
4.06
g/l
1.23
111
238
212
751
3.43
48.01
5.7
7.1
5.96
5.07
kpa
9.83
207
717
211
751
3.41
47.37
5.7
7.1
10.64
12.41
kpa
8.71
205
719
208
749
3.35
45.68
5.7
7.0
4.12
0.59
mmol/l
23.85
184
607
102
222
5.09
44.86
1.3
2.1
10.08
10.73
g/l
0.57
95
201
75
162
4.98
33.08
1.6
2.3
261.27
453.32
ug/l
0.64
68
152
452
2796
2.32
31.47
3.5
5.3
36.20
35.09
g/l
4.44
429
2628
76
174
4.70
31.25
1.4
1.7
0.00
0.00
g/l
-0.00
70
163
78
191
4.40
29.46
1.5
1.7
0.00
0.06
g/l
0.80
72
169
86
228
4.08
29.25
1.5
2.0
0.63
1.57
g/l
0.96
78
190
76
187
4.37
28.51
1.4
1.8
0.00
0.00
g/l
-0.00
70
163
123
429
3.18
27.60
1.8
3.5
10.64
11.03
g/l
0.51
108
401
213
1020
2.45
25.89
1.7
1.8
—
—
—
0
0
125
2753
0.36
25.60
1.9
1.8
1.31
1.27
mmol/l
0.24
111
2265
209
1025
2.38
23.88
2.4
3.8
0.83
0.82
mmol/l
0.23
190
968
80
235
3.65
23.44
1.7
1.9
38.70
38.55
u/l
0.02
74
199
183
866
2.42
22.53
1.7
1.6
1140.36
1147.03
nmol/l
0.03
144
655
460
3143
2.01
21.78
6.4
7.3
1.22
1.21
mmol/l
4.32
397
2711
28
37
7.79
20.05
1.0
2.1
—
—
—
0
0
162
762
2.39
20.03
1.7
1.7
—
—
—
0
0
152
720
2.35
18.39
1.7
1.7
—
—
—
0
0
51
133
4.02
17.66
3.0
2.2
142.60
127.34
g/l
4.67
43
100
554
6655
0.52
17.36
4.3
5.6
2.77
2.71
mmol/l
0.82
486
6087
407
2811
1.86
17.23
6.7
6.6
1.22
1.21
mmol/l
1.42
377
2606
542
6546
0.52
17.06
4.0
4.9
4.70
4.62
mmol/l
0.94
475
6010
538
6504
0.53
16.78
4.0
4.8
1.49
1.47
mmol/l
0.70
471
5934
486
3600
1.82
15.91
5.2
4.5
6.41
6.78
mmol/l
5.42
472
3413
20
6
34.08
15.79
1.1
1.0
23.88
27.83
ng/l
—
14
6
19
6
32.34
14.85
1.1
1.0
284.21
243.33
ng/l
—
14
6
18
6
30.60
13.92
1.1
1.0
872.80
968.50
ng/l
—
10
6
201
1177
1.93
13.65
1.5
1.7
453.10
33678108.60
pmol/l
1.25
173
968
410
2978
1.73
13.53
14.3
16.5
1.30
1.31
inr
0.17
345
2440
521
6201
0.59
12.19
3.6
4.1
1.23
1.24
mmol/l
0.09
453
5606
528
6205
0.60
10.74
5.1
6.0
37.96
39.31
mmol/mol
3.95
477
5719
248
1662
1.70
10.36
1.6
1.6
21.36
19.95
nmol/l
0.81
222
1345
146
845
1.88
10.03
4.3
6.0
1.03
1.07
mmol/l
0.98
135
788
367
2739
1.60
9.89
2.1
1.9
94.23
94.76
pmol/l
0.07
199
1398
87
425
2.17
9.58
6.6
8.6
27.06
24.18
mmol/l
10.27
82
417
81
386
2.21
9.48
1.6
1.6
—
—
—
0
0
122
687
1.91
9.07
4.0
4.1
4.16
1.57
mmol/l
8.05
113
565
155
2359
0.58
8.52
3.4
4.1
9.57
7.75
mg/mmol
0.22
91
1449
104
574
1.93
8.20
7.0
7.5
1.06
1.27
mmol/l
2.73
99
566
37
135
2.82
7.63
1.2
1.3
—
—
—
0
0
14
16
8.88
7.06
1.0
1.1
—
—
—
0
0
80
426
1.97
7.00
1.7
2.3
427.70
398.27
nmol/l
0.74
71
401
15
20
7.61
6.92
4.7
2.3
74.24
64.11
ug/l
0.20
15
20
668
7238
0.64
6.32
24.9
21.8
135.13
135.62
g/l
0.41
663
7116
668
7236
0.64
6.27
25.5
22.0
40.29
40.34
%
0.08
662
7102
668
7236
0.64
6.27
24.7
21.6
4.45
4.49
e12/l
1.27
648
6987
668
7235
0.64
6.24
24.6
21.5
91.65
91.38
fl
0.79
661
7108
668
7234
0.64
6.22
24.7
21.6
245.13
242.79
e9/l
0.46
651
7012
10
8
12.63
6.09
1.1
1.0
—
—
—
0
0
10
8
12.63
6.09
1.1
1.0
—
—
—
0
0
566
6322
0.69
6.00
15.7
14.9
92.50
75.86
ml/min/173m2
34.63
510
5780
537
4624
1.44
5.97
4.1
3.9
11.18
13.35
mm/h
3.07
509
4274
281
2152
1.46
5.94
2.7
4.2
2.37
2.36
mmol/l
0.82
256
1942
171
2372
0.65
5.86
3.1
3.3
7.36
7.48
mmol/l
0.14
140
1968
286
2204
1.45
5.83
4.2
3.2
55.53
74.10
ng/l
0.36
254
1637
9
7
12.98
5.59
3.9
1.9
—
—
—
0
0
571
6344
0.69
5.58
4.3
4.9
5.82
5.93
mmol/l
1.69
519
5720
104
650
1.68
5.41
3.9
2.8
—
—
—
0
0
646
7001
0.68
5.29
10.7
11.5
34.83
25.55
u/l
4.43
628
6735
24
85
2.88
5.28
2.3
1.3
7.17
9.01
u/l
0.37
14
71
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
474
4045
1.39
5.20
5.1
3.9
2246.18
3477.57
e6/l
0.18
11
53
438
3696
1.38
5.11
6.2
10.2
4.05
4.10
e9/l
0.20
371
3130
128
1843
0.64
5.11
2.6
3.4
0.81
0.87
ug/l
0.32
97
1261
9
9
10.09
5.03
1.1
1.0
—
—
—
0
0
74
430
1.79
4.99
4.1
4.4
26.53
23.84
mmol/l
7.23
74
425
11
16
6.95
4.96
1.0
1.0
—
—
—
0
0
8
8
10.08
4.52
1.3
1.0
—
—
—
0
0
78
477
1.70
4.42
4.1
3.8
63.62
92.70
ng/l
3.49
70
429
8
9
8.96
4.28
1.1
1.0
—
—
—
0
0
37
179
2.12
4.27
1.3
1.2
—
—
—
0
0
492
5510
0.74
4.19
22.9
18.8
332.09
332.24
g/l
0.13
486
5465
31
141
2.24
4.16
1.2
1.2
—
1.88
—
0
5
7
7
10.07
4.01
1.0
1.0
—
—
—
0
0
43
230
1.92
3.80
1.7
1.9
—
—
—
0
0
27
121
2.27
3.77
1.5
1.3
0.37
0.26
mg/l
0.56
14
52
662
7059
0.72
3.77
21.0
19.4
63.29
81.27
umol/l
47.39
656
6940
73
461
1.64
3.69
1.4
1.4
—
—
—
0
0
39
204
1.96
3.68
1.6
1.8
—
—
—
0
0
68
423
1.66
3.65
1.5
1.5
1.42
1.37
%
0.21
59
365
40
212
1.93
3.64
1.6
1.6
10.47
6.67
iu/ml
—
10
39
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
9
7.83
3.56
1.0
1.0
—
—
—
0
0
7
9
7.83
3.56
1.0
1.0
—
—
—
0
0
7
9
7.83
3.56
1.1
1.0
—
—
—
0
0
10
21
4.81
3.56
1.0
1.1
—
—
—
0
0
8
13
6.20
3.50
1.0
1.0
—
—
—
0
0
243
1962
1.33
3.44
2.8
3.3
44.24
37.29
u/l
0.54
235
1840
10
23
4.39
3.31
1.0
2.6
41.26
39.17
g/l
—
10
23
160
1218
1.39
3.29
3.7
3.5
672.45
672.13
ng/l
0.00
140
1014
504
4533
1.28
3.01
3.5
3.7
15.29
14.93
pmol/l
2.46
476
4076
65
421
1.59
3.00
1.6
1.6
—
—
—
0
0
9
21
4.32
3.00
1.1
1.0
—
—
—
0
0
79
537
1.52
2.96
3.2
2.8
157.62
236.14
ng/l
1.38
73
487
159
1235
1.35
2.88
1.8
1.6
1.25
1.51
mg/l
0.69
126
966
57
868
0.63
2.87
2.9
5.3
10.89
37.83
ug/l
1.21
46
731
5
174
0.28
2.85
1.0
1.2
1.36
1.56
g/l
—
5
174
387
3390
1.26
2.81
4.9
7.6
12.18
12.96
umol/l
0.56
374
3241
12
43
2.82
2.65
2.1
1.7
6.38
7.67
mmol/l
1.14
12
43
146
1140
1.34
2.55
1.4
1.3
1.03
1.36
u/ml
0.45
30
278
203
2431
0.78
2.40
3.9
4.8
21.58
21.75
%
0.07
113
1343
70
489
1.47
2.34
2.6
2.3
12.94
7.29
ug/l
0.61
63
448
11
40
2.77
2.28
2.0
4.2
—
—
—
0
0
28
157
1.81
2.24
4.4
4.2
68.11
63.77
%
0.54
28
157
68
477
1.46
2.23
2.9
4.5
1.22
1.23
mmol/l
0.90
54
418
21
107
1.99
2.22
1.2
1.2
—
—
—
0
0
21
107
1.99
2.22
1.2
1.2
—
—
—
0
0
259
2982
0.81
2.10
4.1
6.1
5.45
3.69
ug/l
0.34
225
2702
7
21
3.35
1.97
6.0
2.4
5.72
4.98
kpa
—
7
21
7
21
3.35
1.97
6.0
2.4
9.07
10.85
kpa
—
7
21
420
3808
1.20
1.96
3.3
2.8
39.05
51.77
u/l
4.98
398
3508
30
180
1.69
1.94
1.4
1.6
—
—
—
0
0
6
16
3.77
1.93
1.7
2.1
—
—
—
0
0
218
1861
1.23
1.86
3.4
3.3
0.78
0.57
e6/l
0.47
159
1343
47
677
0.68
1.86
1.4
1.4
—
—
—
0
0
240
2070
1.22
1.86
3.1
3.1
960.67
1550.04
ng/l
2.35
202
1834
272
2376
1.21
1.85
3.6
3.3
—
—
—
0
0
8
182
0.43
1.83
1.4
3.4
13.14
859.96
u/ml
—
8
170
26
154
1.71
1.78
1.5
1.4
—
—
—
0
0
247
2148
1.21
1.75
3.5
3.3
43.83
88.76
e6/l
0.94
183
1618
152
1263
1.25
1.66
2.6
3.4
2.46
2.47
mmol/l
0.20
134
1139
535
5006
1.19
1.62
6.4
8.4
72.66
82.01
u/l
8.71
506
4737
10
43
2.34
1.59
1.7
1.1
—
—
—
0
0
10
44
2.29
1.56
1.7
1.1
—
—
—
0
0
301
2692
1.18
1.55
2.8
2.3
78.97
79.95
nmol/l
0.22
265
2410
8
33
2.44
1.54
1.3
2.0
—
—
—
0
0
145
1721
0.81
1.53
2.5
2.9
339.34
357.27
umol/l
1.35
125
1518
119
973
1.26
1.51
1.3
1.2
31.14
41.59
iu/ml
0.25
28
297
13
65
2.02
1.49
1.2
1.9
—
—
—
0
0
34
228
1.51
1.46
1.8
2.4
—
—
—
0
0
6
22
2.74
1.43
1.0
1.3
—
—
—
0
0
28
181
1.57
1.41
1.4
1.6
—
—
—
0
0
11
53
2.09
1.39
1.4
1.3
—
—
—
0
0
20
120
1.68
1.35
1.4
1.7
—
—
—
0
0
654
6791
0.84
1.34
20.5
16.9
139.77
139.76
mmol/l
0.01
645
6621
655
6800
0.84
1.34
20.5
17.1
3.94
4.00
mmol/l
7.91
642
6611
12
61
1.98
1.33
1.2
1.9
—
—
—
0
0
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
46
337
1.39
1.28
1.3
1.2
262.99
230.66
u/ml
0.12
41
314
40
287
1.41
1.25
1.4
1.3
—
—
—
0
0
6
25
2.41
1.24
1.2
1.8
—
—
—
0
0
6
25
2.41
1.24
1.2
1.8
—
—
—
0
0
8
36
2.23
1.24
2.1
1.4
—
—
—
0
0
9
45
2.01
1.23
2.0
1.4
—
—
—
0
0
20
124
1.63
1.21
1.6
1.4
—
—
—
0
0
8
37
2.17
1.21
1.1
1.7
—
—
—
0
0
8
37
2.17
1.21
1.1
1.7
—
—
—
0
0
8
37
2.17
1.21
1.1
1.7
—
—
—
0
0
8
37
2.17
1.21
1.1
1.7
—
—
—
0
0
18
109
1.67
1.19
1.7
1.4
—
—
—
0
0
6
26
2.32
1.19
1.2
1.8
—
—
—
0
0
8
38
2.12
1.18
2.1
1.5
—
—
—
0
0
26
174
1.51
1.16
2.7
3.4
2.31
2.17
index
0.03
13
90
20
126
1.60
1.15
1.2
1.2
—
—
—
0
0
7
138
0.50
1.10
2.0
5.6
—
238.21
—
0
19
12
66
1.83
1.09
1.1
1.6
—
—
—
0
0
12
66
1.83
1.09
1.1
1.6
—
—
—
0
0
12
66
1.83
1.09
1.1
1.6
—
—
—
0
0
5
21
2.39
1.09
1.2
2.8
—
—
—
0
0
7
32
2.20
1.08
5.3
3.8
26.57
19.17
nmol/l
—
7
32
10
52
1.93
1.06
1.0
1.1
2.00
3.21
u/ml
—
5
24
8
150
0.53
1.04
1.3
1.2
—
—
—
0
0
5
107
0.46
1.01
2.6
3.9
—
2004.67
—
0
9
7
35
2.01
1.00
1.0
1.2
—
—
—
0
0
7
35
2.01
1.00
1.0
3.2
1388.71
1300.57
u/ml
—
7
35
138
1199
1.18
1.00
3.2
3.0
1.15
1.02
e6/l
0.18
85
655
9
50
1.81
0.97
1.0
1.2
—
—
—
0
0
0
31
0.00
0.96
0.0
1.3
—
10.58
—
0
31
20
133
1.52
0.95
1.7
1.4
—
—
—
0
0
6
31
1.94
0.84
2.0
2.5
224.17
237.58
e6/l
—
6
26
23
163
1.42
0.82
1.4
1.3
—
—
—
0
0
127
1117
1.16
0.81
3.2
3.2
1.41
1.58
e6/l
0.15
73
574
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
18
123
1.47
0.78
2.3
1.3
38.73
34.24
iu/l
0.12
12
107
125
1105
1.15
0.75
1.9
2.6
13.80
12.58
umol/l
0.86
111
1052
11
67
1.65
0.75
1.2
1.2
—
—
—
0
0
591
5713
1.11
0.74
4.3
4.4
1.94
2.07
mu/l
1.38
557
5112
9
54
1.67
0.74
1.0
1.5
—
106.25
—
0
8
10
160
0.62
0.74
1.4
1.3
—
—
—
0
0
13
84
1.56
0.72
1.5
1.5
—
—
—
0
0
9
58
1.56
0.70
1.1
1.2
103.44
103.83
pmol/l
—
9
58
9
58
1.56
0.70
3.4
2.4
—
—
—
0
0
26
198
1.32
0.64
5.1
4.6
1.26
1.57
mg/l
0.96
26
172
8
127
0.63
0.64
1.1
1.5
—
—
—
0
0
101
892
1.15
0.63
3.0
4.7
237.65
255.55
u/l
0.68
96
856
6
101
0.59
0.62
1.0
1.1
—
—
—
0
0
8
49
1.64
0.62
1.6
1.4
—
—
—
0
0
157
1430
1.12
0.62
3.0
2.6
6.99
5.68
e6/l
0.37
142
1291
346
3281
1.09
0.61
2.7
2.3
—
—
—
0
0
87
763
1.16
0.61
7.5
6.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
1.30
—
0
8
15
105
1.44
0.60
1.1
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
10.3
—
6.07
—
0
21
0
22
0.00
0.59
0.0
1.1
—
9.19
—
0
9
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
5
87
0.57
0.56
1.4
1.1
—
1.34
—
0
5
18
133
1.36
0.55
1.2
1.3
—
—
—
0
0
11
74
1.49
0.53
1.0
1.0
—
16.29
—
0
16
6
99
0.60
0.52
1.5
1.5
—
—
—
0
0
12
84
1.43
0.49
1.2
1.4
—
—
—
0
0
80
898
0.88
0.49
1.3
1.2
7.45
17.68
u/ml
1.33
30
338
195
1828
1.09
0.45
3.9
3.4
0.00
0.01
estimate
0.78
65
615
7
50
1.40
0.45
1.0
1.4
0.20
0.19
nmol/l
—
7
38
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
1.8
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
30
250
1.21
0.41
1.7
4.5
33.63
54.17
mg/l
0.93
23
224
12
88
1.37
0.40
1.6
1.5
—
—
—
0
0
113
1041
1.10
0.39
1.7
2.6
2.23
2.25
g/l
0.15
97
981
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
217
1.20
0.36
2.7
2.6
0.35
0.31
iu/ml
0.29
15
114
35
301
1.17
0.35
1.1
1.2
95.17
156.14
u/ml
—
9
107
6
43
1.40
0.35
1.0
1.3
—
—
—
0
0
6
44
1.37
0.34
1.0
1.4
—
—
—
0
0
6
44
1.37
0.34
1.2
1.1
—
—
—
0
0
6
46
1.31
0.33
1.3
1.1
—
—
—
0
0
105
976
1.09
0.32
1.8
2.6
24.32
22.49
%
0.67
95
927
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
48
536
0.89
0.31
2.6
3.0
107.37
59.65
ml/min/173m2
0.90
19
231
648
6386
1.06
0.30
17.3
14.0
25.53
28.63
mg/l
1.31
575
5023
52
577
0.89
0.30
2.6
2.4
34.95
38.77
u/l
0.34
44
485
29
251
1.16
0.28
1.8
4.5
35.10
283.95
mg/l
0.64
22
222
23
195
1.18
0.28
1.5
1.5
0.58
0.10
iu/ml
—
5
37
154
1616
0.94
0.25
2.0
2.6
—
—
—
0
0
167
1596
1.06
0.25
2.2
2.4
2.76
2.79
mg/l
0.05
138
1371
17
142
1.20
0.24
1.3
1.1
—
—
—
0
0
17
142
1.20
0.24
1.3
1.1
—
—
—
0
0
10
79
1.27
0.22
3.3
4.3
—
—
—
0
0
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
9.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
13
156
0.83
0.21
1.2
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
7.2
—
10.38
—
0
13
74
786
0.94
0.19
3.9
4.7
34.36
32.93
%
0.48
44
462
27
247
1.10
0.13
1.1
1.0
—
—
—
0
0
178
1733
1.03
0.13
3.3
3.0
0.00
0.00
estimate
0.50
63
504
145
1408
1.04
0.13
3.9
3.4
1.02
1.02
kg/l
0.48
101
903
337
3318
1.03
0.12
3.9
3.4
0.00
3.87
estimate
0.80
73
692
30
323
0.93
0.12
2.0
1.7
1.46
1.47
g/l
0.03
25
283
341
3363
1.02
0.11
3.8
3.4
0.00
0.00
estimate
-0.00
73
657
304
2998
1.02
0.10
2.2
2.8
—
—
estimate
—
0
0
5
45
1.11
0.10
1.4
1.3
—
23.14
—
0
7
16
176
0.91
0.09
1.5
1.4
—
—
—
0
0
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
332
3282
1.02
0.08
3.8
3.4
0.00
0.00
estimate
-0.00
73
685
16
146
1.10
0.08
2.3
2.3
12.83
84.68
ug/min
—
6
86
18
166
1.09
0.08
2.2
1.7
—
—
—
0
0
10
112
0.89
0.07
2.5
1.4
—
—
—
0
0
7
81
0.86
0.07
1.0
1.0
—
—
—
0
0
8
91
0.88
0.06
1.0
1.2
1.68
1.54
g/l
—
8
85
21
224
0.94
0.06
2.2
1.3
—
—
—
0
0
75
770
0.97
0.06
1.3
1.4
—
—
—
0
0
14
152
0.92
0.06
1.1
1.3
—
—
—
0
0
16
172
0.93
0.06
1.7
1.6
51.44
43.01
nmol/l
0.52
16
165
23
218
1.06
0.05
1.8
4.2
1.40
6.98
ratio
0.89
11
135
11
120
0.92
0.05
1.2
1.3
231.00
169.42
miu/ml
—
6
58
17
160
1.06
0.04
1.8
1.4
—
—
—
0
0
19
182
1.04
0.02
4.1
3.2
1.78
1.62
mmol/l
0.31
19
177
18
188
0.96
0.02
2.9
2.6
3.56
3.65
g/l
0.08
18
180
187
1878
0.99
0.01
2.3
2.3
51.58
62.08
u/l
3.08
173
1721
249
2482
1.00
0.01
3.8
3.3
0.01
0.03
estimate
0.29
68
551
71
703
1.01
0.01
2.2
2.9
7.67
9.79
umol/l
0.66
61
628
262
2628
1.00
0.01
2.6
2.9
153.11
158.08
ug/l
0.08
239
2444
16
166
0.96
0.00
1.8
1.7
—
—
—
0
0
23
224
1.03
0.00
1.3
1.2
—
—
—
0
0
18
181
0.99
0.00
2.2
2.2
89.83
87.52
%
0.17
18
174
25
253
0.99
0.00
2.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
0.25
—
0
8
0
8
0.00
0.00
0.0
5.4
—
29.13
—
0
8
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.2
1.3
5.50
13.00
u/l
—
6
62
0
7
0.00
-0.00
0.0
1.1
—
9.34
—
0
7
7
75
0.93
-0.00
1.4
1.4
—
—
—
0
0
7
75
0.93
-0.00
1.4
1.4
—
—
—
0
0
7
72
0.97
-0.00
1.4
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
22.96
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
53.80
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
0.34
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.2
—
6.18
—
0
9
7
75
0.93
-0.00
1.4
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
37.06
—
0
7
0
6
0.00
-0.00
0.0
6.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
23.00
—
0
7
0
7
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
9
94
0.96
-0.00
2.7
1.3
—
—
—
0
0
7
72
0.97
-0.00
1.4
1.4
—
—
—
0
0
7
72
0.97
-0.00
1.4
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MND – Motor neuron disease (with DMD)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).